Is the price fair?
What ASH's price assumes
Ashland Inc. trades at 69.2× earnings against 27.9× for the median Specialty Chemicals name, more expensive than its own group.
69.2
Trailing P/E · Specialty Chemicals median 27.9 · 2.48× the median: the market pays up for this one
- Price / sales
- 0.00
Price / sales · as of 2026-Q1
- Free cash flow yield
- 8.5%
Free cash flow yield · Specialty Chemicals median 3.9%
- Growth the price implies
- −1.4%
Growth the price implies · The price pays for −1.4% free cash flow growth a year for a decade; the business has delivered +8.6% a year over the last three.
Details›
- Price / book2026-Q1
- 0.00
- EV / sales2026-Q1
- 0.57
- Basic Materials median P/E159 names
- 22.3
- Specialty Chemicals median P/E37 names
- 27.9
- Free cash flow, trailing twelve months
- $250M
- Market capitalisation
- $2.95B
- 3-year revenue growth
- −7.2%
- 3-year free cash flow growth
- +8.6%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $15.63 |
| Its own P/E history, median | $23.75 |
| Its own P/E history, upper quartile | $29.96 |
| 52-week range | $46.46 – $76.45 |
| Today | $72.64 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Specialty Chemicals
Ranks #9 of 27 by Smart Score